Automatic and Conventional Methods of Hypertensive Patients Monitoring

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

620 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-10-31

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

comparing automatic blood pressure measurments methods with conventional office methods in follow up and monitoring of hypertensive patients and predicting hypertension mediated organ damage .

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparisonbetween Primary Hypertension Monitoring Methods for Detection of Early Kidney Dysfunction

NCT03491813

Primary Hypertension

UNKNOWN

Ambulatory Versus Home Blood Pressure Measurement

NCT01132001

Arterial Hypertension

UNKNOWN

Home Versus Ambulatory Monitoring, Diurnal Blood Pressure Profile, Detection of Non-Dippers

NCT01460732

Hypertension

COMPLETED NA

Mercury Versus Automated Blood Pressure Monitoring

NCT01753895

Healthy Volunteers

COMPLETED

Effect of Smart Phone Based Telemonitoring on Blood Pressure Among Hypertensive Patients in Primary Care

NCT02046993

Hypertension Blood Pressure

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Close monitoring of hypertensive patients using home and ambulatory blood pressure measurments and its role in predicting hypertention mediated organ damage. Echocardiography assessment for hypertensive patients and its important role in early detection and prevention of changes such as left ventricular hypertrophy,left atrial enlargement ,systolic and diastolic dysfunction and left ventricular mass . Microalbumiuria and early detection of renal impairment. Important role of close monitoring in management and control of hypertention and reduction of hypertensive emergencies and improvement of outcomes ,addherence to treatment , reduce of office consultation , improvement of psycosochial life ,reduce hospitalization cost and mortality rates . Digital apps has a good role in improve healthy life style and rapid detection of blood presssure changes during daily activities.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

this group use office conventional methods of blood pressure measurments 3 separate readings at different visits

blood pressure measurments devices

Intervention Type DEVICE

measure arterial blood pressure by arm cuff devises

group 2

divided into 2 groups

1. st group used home methods twice daily in morning and in evening using cuff digital machine
2. nd group use unattended automatic office blood pressure measurments in 3 readings

blood pressure measurments devices

Intervention Type DEVICE

measure arterial blood pressure by arm cuff devises

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

blood pressure measurments devices

measure arterial blood pressure by arm cuff devises

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who were screening for suspected hypertention or white coat hypertention .
* medically underserved population .
* primary arterial hypertention .
* high risk hypertensive patients \[resistant hypertension ,patients with poor medication adherance \]

Exclusion Criteria

* patients with secondary causes of hypertention
* patients with other cardiac diseases \[heart faliure ,valvular heart diseases \]
* chronic illness affect blood pressure as chronic kideny disease .

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes